Both in Pharmaceuticals
Collegium Pharmaceutical vs Aktis Oncology
Over the past year COLL returned −48.0% and AKTS returned −34.9%; their daily moves had a correlation of 0.03.
COLL −48.0% AKTS −34.9%Growth of $1, one year, split-adjusted
| Metric | COLL | AKTS |
|---|---|---|
| Price | $23.68 | $14.59 |
| Market cap | $770.9M | $811.5M |
| Today | −0.50% | −8.41% |
| 1 month | +7.5% | −21.2% |
| 6 months | −31.5% | −23.2% |
| Year to date | −48.9% | — |
| 1 year | −33.6% | — |
| Revenue growth (YoY) | +6.3% | — |
| Gross margin | 86.7% | 100.0% |
| Net margin | −7.5% | −713.5% |
| P/E (TTM) | 16.1× | — |
| Price / sales | 1.0× | — |
| Net cash | -$962.1M | $517.3M |
| Dividend yield | — | — |
| Volatility (60d) | 38.5% | 55.1% |
| Short % of float | 17.6% | 18.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).